Clinical Trial Update: Optimising the Propranolol Block Model [Phase 1]

View source ↗

Summary

Phase 1 trial update on optimizing a Propranolol block model. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED